Antroquinonol

DB12326InvestigationalSmall molecule

Antroquinonol has been used in trials studying the treatment of Hyperlipidemias, Non-small Cell Lung Cancer, and Non-small Cell Lung Cancer Stage IV.

Chemical structure of Antroquinonol
Formula / weight
C24H38O4 · 390.564 g/mol (avg)
Also known as
HOCENA
Code names
J3.387.174K

Resolves to

Compound
UNIIAX9P92T7JZCAS1010081-09-0ChEMBLCHEMBL3235620ChEBI65415PubChem24875259
Structure
InChIKeyLJTSIMVOOOLKOL-FNRDIUJOSA-NSMILESCOC1=C(OC)C(=O)[C@H](C)[C@@H](C\C=C(/C)CC\C=C(/C)CCC=C(C)C)[C@H]1O
Targets
P26358DNMT1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Antroquinonol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In